Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Madrigal Pharmaceuticals Inc (MDGL)  
$229.58 5.27 (2.24%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 19,740,000
Market Cap: 4.53(B)
Last Volume: 9,322,967 Avg Vol: 9,297,425
52 Week Range: $120.4 - $284.88
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 21.9
Insider 3/6 Months : 22.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Co.'s primary product candidate, resmetirom, is being developed as a once-daily oral pill to treat several disease states, including non-alcoholic steatohepatitis, or NASH. Co. has initiated MAESTRO-NASH, a Phase 3 trial in NASH with its once daily, oral thyroid hormone receptor beta selective agonist, resmetirom. Co. has opened for enrollment MAESTRO-NAFLD-1, a Phase 3 clinical study of patients with biopsy-confirmed or presumed NASH recruited from sites in the U.S.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 136,370 424,685 424,685
Total Buy Value $0 $30,065,193 $77,751,391 $77,751,391
Total People Bought 0 1 1 1
Total Buy Transactions 0 3 10 10
Total Shares Sold 276,067 293,667 293,667 363,156
Total Sell Value $67,426,178 $71,246,652 $71,246,652 $90,715,080
Total People Sold 7 8 8 9
Total Sell Transactions 15 23 23 28
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 416
  Page 11 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rieder Wendy E VP, IP and Legal, Gen. Counsel   •       –      –    2012-06-18 4 AS $6.00 $43,020 D/D (7,170) 19,823     -
   Rieder Wendy E VP, IP and Legal, Gen. Counsel   •       –      –    2012-06-18 4 OE $2.49 $17,853 D/D 7,170 26,993     -
   Rieder Wendy E VP, IP and Legal, Gen. Counsel   •       –      –    2012-06-04 4 AS $5.50 $39,435 D/D (7,170) 19,823     -
   Rieder Wendy E VP, IP and Legal, Gen. Counsel   •       –      –    2012-06-04 4 OE $2.49 $17,853 D/D 7,170 26,993     -
   Ehrlich Keith S VP, Fin. and Admin., CFO   •       –      –    2012-03-01 4 AS $4.70 $20,662 D/D (4,397) 17,573     -
   Vukovic Vojo SVP, Chief Medical Officer   •       –      –    2012-03-01 4 AS $4.70 $12,006 D/D (2,555) 22,249     -
   Koya Keizo Sr. VP, Drug Development   •       –      –    2012-03-01 4 AS $4.70 $32,187 D/D (6,844) 12,999     -
   Kovner Bruce Director   –       •       •   2012-01-06 4 B $4.40 $4,999,997 D/D 1,136,363 5,906,048 3.92     -
   Kovner Bruce Director   –       •       •   2011-12-13 4 GA $0.00 $0 I/I 500,000 125,000     -
   Kovner Bruce Director   –       •       •   2011-12-13 4 GD $0.00 $0 D/D 500,000 4,769,685     -
   Kovner Bruce Director   –       •       •   2011-12-07 4 B $3.95 $43,727 D/D 11,059 5,269,685 3.92     -
   Chen Lan Bo Director   –       •      –    2011-12-06 5 GA $0.00 $0 I/I 25,400 249,831     -
   Chen Lan Bo Director   –       •      –    2011-12-06 5 GD $0.00 $0 I/I 38,100 952,606     -
   Kovner Bruce Director   –       •       •   2011-11-29 4 B $3.96 $35,024 D/D 8,844 5,258,626 3.92     -
   Kovner Bruce Director   –       •       •   2011-11-25 4 B $3.94 $98,473 D/D 25,016 5,249,782 3.92     -
   Kovner Bruce Director   –       •       •   2011-11-23 4 B $3.98 $30,039 D/D 7,547 5,224,766 3.92     -
   Kovner Bruce Director   –       •       •   2011-11-22 4 B $3.96 $1,793 D/D 453 5,217,219 3.84     -
   Kovner Bruce Director   –       •       •   2011-11-21 4 B $3.84 $129,299 D/D 33,640 5,216,766 3.92     -
   Kovner Bruce Director   –       •       •   2011-11-18 4 B $3.71 $77,921 D/D 21,000 5,183,126 3.92     -
   Kovner Bruce Director   –       •       •   2011-09-12 4 B $3.82 $164,455 D/D 43,085 5,162,126 3.92     -
   Kovner Bruce Director   –       •       •   2011-09-09 4 B $3.77 $415,702 D/D 110,149 5,119,041 3.92     -
   Kovner Bruce Director   –       •       •   2011-09-06 4 B $3.79 $191,258 D/D 50,400 5,008,892 3.92     -
   Kovner Bruce Director   –       •       •   2011-09-02 4 B $3.89 $179,245 D/D 46,057 4,958,492 3.92     -
   Vukovic Vojo SVP, Chief Medical Officer   •       –      –    2011-09-02 4 B $4.00 $8,752 D/D 2,188 24,804 2.74     -
   Vukovic Vojo SVP, Chief Medical Officer   •       –      –    2011-09-01 4 B $4.07 $1,270 D/D 312 22,616 2.66     -
  416 Records found
  Previous  10  11  12  13  14  15  16  17   
  Page 11 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us